Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane eye drops for pediatric blepharokeratoconjunctivitis
ChiCTR2600136047Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of perfluorohexyloctane in blepharokeratoconjunctivitis (BKC) (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Ocular Surface Disease Index score and Corneal fluorescein staining. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
blepharokeratoconjunctivitis (BKC)
Beyond the preview
Go deeper on ChiCTR2600136047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600136047.